STE

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Steris Plc

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
CEO
Walter Rosebrough
Employees
13000
Headquarters

Rutherford House
Stephensons Way
Leicester, Leicestershire DE21 6LY
Phone: 4403542600
www.steris.com

News

STERIS plc (Ireland) – Consensus Indicates Potential 12.0% Upside
Aug 16, 2022 11:49am

STERIS plc (Ireland) found using ticker (STE) now have 6 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 250 and 225 with a mean TP of 239.5. With the stocks previous close at 213.9 this is indicating there is a potential upside of 12.0%. The 50 day moving average now sits at 211.71 and the 200 moving average now moves to 226.78. The company has a market cap of $21,399m. Visit the company website at: https://www.steris.com [stock_market_widget type="chart" template="basic" color="green" assets="STE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $23,960m based on the market concensus. STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.


Source:DirectorsTalk
STERIS plc (Ireland) – Consensus Indicates Potential 13.9% Upside
Aug 13, 2022 11:58am

STERIS plc (Ireland) found using ticker (STE) have now 6 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 250 and 225 with the average target price sitting at 239.5. With the stocks previous close at 210.21 this now indicates there is a potential upside of 13.9%. The 50 day MA is 211.97 and the 200 moving average now moves to 226.87. The market capitalisation for the company is $21,407m. Company Website: https://www.steris.com [stock_market_widget type="chart" template="basic" color="green" assets="STE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $24,390m based on the market concensus. STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.


Source:DirectorsTalk
U.S. economy still shows good growth, in this week’s R&D Power Index
Aug 08, 2022 00:00am

The R&D World Index (RDWI) for the week ending August 5, 2022 closed at 2,491.02 for the 25 companies in the RDWI. The Index was down -1.17% (or -29.41 basis points) from the week ending July 29, 2022.  Nine of the 25 RDWI members gained value from 0.02% (Sanofi SA) to 5.03% (Facebook/Meta Platforms Inc.).…


Source:WTWH
STERIS plc (Ireland) – Consensus Indicates Potential 16.8% Upside
Aug 07, 2022 13:36pm

STERIS plc (Ireland) with ticker code (STE) now have 6 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 270 and 225 with a mean TP of 242.83. Given that the stocks previous close was at 207.99 this would indicate that there is a potential upside of 16.8%. The 50 day moving average now sits at 213.71 while the 200 day moving average is 227.41. The market cap for the company is $21,215m. You can visit the company''s website by visiting: https://www.steris.com [stock_market_widget type="chart" template="basic" color="green" assets="STE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $24,769m based on the market concensus. STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.


Source:DirectorsTalk
STERIS PT Lowered to $240 at KeyBanc
Aug 04, 2022 08:02am

https://www.investing.com/news/pro/steris-pt-lowered-to-240-at-keybanc-432SI-2862915


Source:Investing.com
STERIS PT Lowered to $225 at Wolfe Research
Aug 04, 2022 08:00am

https://www.investing.com/news/pro/steris-pt-lowered-to-225-at-wolfe-research-432SI-2862906


Source:Investing.com
STERIS plc. (STE) CEO Dan Carestio on Q1 2023 Results - Earnings Call Transcript
Aug 03, 2022 20:23pm

STERIS plc. (NYSE:NYSE:STE) Q1 2023 Earnings Conference Call August 03, 2022 10:00 AM ET Company Participants Julie Winter - Vice President-Investor Relations Mike Tokich - Senior Vice…


Source:Seeking Alpha
Steris: Q1 Earnings Insights
Aug 02, 2022 21:43pm

Steris (NYSE: STE ) reported its Q1 earnings results on Tuesday, August 2, 2022 at 04:30 PM. Here''s what investors need to know about the announcement. Earnings Steris missed estimated earnings by 0.52%, reporting an EPS of $1.9 versus an estimate of $1.91. Revenue was up $187.58 million from the same period last … Full story available on Benzinga.com


Source:Benzinga
Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M
Aug 02, 2022 20:57pm

Steris press release (STE): Q1 Non-GAAP EPS of $1.90 in-line.Revenue of $1.2B (+23.9% Y/Y) misses by $20M.For fiscal 2023, constant currency organic revenue growth is now anticipated…


Source:Seeking Alpha
Steris Cuts Outlook on Supply Chain Challenges, Lighter Volumes
Aug 02, 2022 20:32pm

(PLX AI) – Steris Q1 EPS USD 1.1.Q1 adjusted EPS USD 1.9Outlook FY organic growth 10%, down from 11% previouslyOutlook FY adjusted EPS USD 8.4-8.6, down from USD 8.55-8.75 previouslySays ongoing supply chain challenges and procedure volumes somewhat …


Source:Wallstreet:Online
STERIS Announces Financial Results for Fiscal 2023 First Quarter
Aug 02, 2022 20:30pm

DUBLIN, IRELAND, Aug. 02, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 first quarter ended June 30, 2022. Revenue as reported for the quarter increased 19% to $1.2 billion compared with $968.4 million in the first quarter of fiscal 2022. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 6% for the first quarter of fiscal 2023 as compared to the first quarter of fiscal 2022.


Source:GlobeNewswire
New Tigo tool will help identify powerline communications issues in design phase
Aug 02, 2022 00:00am

Tigo has unveiled the Solar PLC Signal Integrity Tool and expanded training material to empower solar installers and EPCs to provide high-quality solar solutions for C&I solar system owners. Following the recently announced Tigo Pure Signal technology, Tigo is once again leveraging its technical expertise for its customers with a design validation tool and companion…


Source:WTWH
Steris shares drop on Q1 swing-and-miss, lowered outlook
Aug 02, 2022 00:00am

Steris (NYSE:STE) posted first-quarter results today that fell short of the consensus forecast on Wall Street and reduced its outlook for the rest of the year, despite swinging to a profit from a loss a year ago. The infection prevention technology company — headquartered in Dublin, Ireland, and run operationally out of Mentor, Ohio — […]


Source:WTWH
Steris FQ1 2023 Earnings Preview
Aug 01, 2022 21:35pm

Steris (STE) is scheduled to announce FQ1 earnings results on Tuesday, August 2nd, after market close.The consensus EPS Estimate is $1.90 (+8.0% Y/Y) and the consensus Revenue Estimate…


Source:Seeking Alpha
STERIS plc (Ireland) – Consensus Indicates Potential 15.4% Upside
Aug 01, 2022 06:38am

STERIS plc (Ireland) found using ticker (STE) have now 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 295 and 240 calculating the average target price we see 259.83. With the stocks previous close at 225.11 this would imply there is a potential upside of 15.4%. The 50 day MA is 214.81 while the 200 day moving average is 227.65. The company has a market cap of $22,583m. Company Website: https://www.steris.com [stock_market_widget type="chart" template="basic" color="green" assets="STE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $26,066m based on the market concensus. STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.


Source:DirectorsTalk
Steris declares $0.47/share interim dividend
Jul 28, 2022 20:33pm

Steris (STE) declares $0.47/share interim dividend, a $0.04 increase from previous interim dividend of $0.43.


Source:Seeking Alpha
STERIS Raises Dividend to $0.47 per share
Jul 28, 2022 20:30pm

DUBLIN, IRELAND, July 28, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share. This represents a $0.04 increase in the dividend and the Company’s 17 th consecutive year of dividend growth.


Source:GlobeNewswire
STERIS to Host a Conference Call for Fiscal 2023 First Quarter Financial Results on August 3, 2022
Jul 20, 2022 20:30pm

DUBLIN, IRELAND, July 20, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 first quarter financial results at 10:00 a.m. ET on August 3, 2022. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.


Source:GlobeNewswire
STERIS plc (Ireland) – Consensus Indicates Potential 27.3% Upside
Jul 10, 2022 11:59am

STERIS plc (Ireland) found using ticker (STE) have now 5 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 295 and 248 with the average target price sitting at 263.8. Now with the previous closing price of 207.2 this is indicating there is a potential upside of 27.3%. The day 50 moving average is 217.14 while the 200 day moving average is 227.58. The company has a market cap of $20,957m. Find out more information at: https://www.steris.com [stock_market_widget type="chart" template="basic" color="green" assets="STE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $26,681m based on the market concensus. STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.


Source:DirectorsTalk
STERIS plc (Ireland) – Consensus Indicates Potential 28.0% Upside
Jul 04, 2022 10:23am

STERIS plc (Ireland) with ticker code (STE) now have 5 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 295 and 248 and has a mean target at 263.8. Now with the previous closing price of 206.15 this now indicates there is a potential upside of 28.0%. There is a 50 day moving average of 219.48 and the 200 moving average now moves to 227.68. The company has a market capitalisation of $21,113m. Visit the company website at: https://www.steris.com [stock_market_widget type="chart" template="basic" color="green" assets="STE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $27,017m based on the market concensus. STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.


Source:DirectorsTalk
Pushing performance: Adding functionality to terminal blocks
Jul 01, 2022 00:00am

By Clayton Windsor Terminal blocks are used industry wide and often thought of as a simple component to connect one wire to another. Most of the time that is exactly the case. However, there are many different varieties of terminals that users can consider, including additional functionality such as fusing, disconnect, or electronic components for…


Source:WTWH
STERIS plc (NYSE: STE): What’s Next In 2022?
Jun 25, 2022 14:30pm

STERIS plc (NYSE:STE) shares, rose in value on Friday, 06/24/22, with the stock price up by 2.69% to the previous day’s close as strong demand from buyers drove the stock to $207.89. Actively observing the price movement in the last trading, the stock closed the session at $202.44, falling within a range of $203.11 and … STERIS plc (NYSE: STE): What’s Next In 2022? Read More »


Source:Stocks Register
Endoscope Washer-Disinfectors Market to Witness Huge Growth by Key Players: Medivators, Olympus, Steris, Getinge, Wassenburg Medical, Shinva Medical
Jun 25, 2022 06:36am

The Endoscope Washer-Disinfectors report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a


Source:OpenPR